Psychopharmacologia

, Volume 42, Issue 1, pp 73–77 | Cite as

The role of noradrenaline, dopamine and 5-hydroxytryptamine in the hyperactivity response resulting from the administration of tranylcypromine to rats pretreated with lithium or rubidium

  • A. Judd
  • Judith Parker
  • F. A. Jenner
Laboratory Studies

Abstract

  1. 1.

    The administration of 15 mg/kg tranylcypromine sulphate (Tc) to rats which have been given lithium chloride (LiCl) in the diet (30 mmol/kg dry food) for 14 days produces hyperactivity within 4 hrs, and this lasts for at least 4 further hours.

     
  2. 2.

    If LiCl is replaced by rubidium chloride (RbCl) at the same dose, the hyperactivity following Tc is increased and it appears within 2 hrs.

     
  3. 3.

    5-Hydroxytryptamine (5HT) accumulation after a monoamine oxidase inhibitor (Tc) is increased 46% and 85% respectively above control values by LiCl and RbCl administration.

     
  4. 4.

    The hyperactivity produced by the above combinations is inhibited by α-methyl-p-tyrosine (αmpt). The inhibition is more effective following LiCl than RbCl treatment.

     
  5. 5.

    After sodium chloride (NaCl) and LiCl treatment, but not after RbCl treatment, the combination of αmpt and Tc produces rat brain concentrations of dopamine (DA) significantly below control values.

     
  6. 6.

    The smaller increase of brain noradrenaline (NA) after Tc and RbCl suggests that a lower percentage of NA is being metabolised by MAO. The greater decrease of NA after giving αmpt to RbCl and LiCl treated rats suggests an increased “turnover” rate of Na.

     
  7. 7.

    The hyperactivity syndrome seen in rats after the administration of LiCl or RbCl and Tc is dependent upon both 5HT and dopamine mechanisms.

     

Key words

Activity Brain Catecholamines 5-Hydroxytryptamine Lithium Rubidium Tranylcypromine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bond, P. A., Brooks, B. A., Judd, A.: The distribution of lithium, sodium and magnesium in rat brain and plasma after various periods of administration of lithium in the diet. Brit. J. Pharmacol. (in press, 1974)Google Scholar
  2. Carrol, B. J., Sharp, P. T.: Rubidium and lithium: opposite effects on amine mediated excitement. Science 172, 1355–1357 (1971)Google Scholar
  3. Corrodi, H., Fuxe, K., Hökfelt, T., Schou, M.: The effect of lithium on cerebral monoamine neurones. Psychopharmacologia (Berl.) 11, 345–353 (1967)Google Scholar
  4. Corrodi, H., Fuxe, K., Schou, M.: The effect of prolonged lithium administration on cerebral monoamine neurones in the rat. Life Sci. 8, 643–651 (1969)Google Scholar
  5. Donaldson, J., Minnich, J. L., Barbeau, A.: Effet du lithium et du rubidium sur les monoamines cérébrales de la souris. Univ. Medicale du Canadianne 102, 907–911 (1973).Google Scholar
  6. Grahame-Smith, D. G.: Personal communication. (1974)Google Scholar
  7. Grahame-Smith, D. G., Green, A. R.: The role of brain dopamine in the hyperactivity syndrome produced in rats after administration of L-tryptophan and a monoamine oxidase inhibitor. Brit. J. Pharmacol. 50, 442–443P (1974a)Google Scholar
  8. Grahame-Smith, D. G., Green, A. R.: The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition. Brit. J. Pharmacol, (in press, 1974b)Google Scholar
  9. Jenner, F. A.: Lithium and affective psychoses. Biochem. Soc. Spec. Publ. 1, 101–111 (1973)Google Scholar
  10. Leonard, B. E., Shallice, S. A.: Some neurochemical effects of amphetamine, methylamphetamine and p-homomethylamphetamine in the rat. Brit. J. Pharmacol. 41, 198–212 (1971)Google Scholar
  11. Perez-Cruet, J., Tagliamonte, A., Tagliamonte, P., Gessa, G. L.: Stimulation of serotonin synthesis by lithium. J. Pharmacol. exp. Ther. 178, 325–330 (1971)Google Scholar
  12. Stolk, J. M., Conner, R. L., Barchas, J. D.: Rubidium induced increase in shock-elicited aggression in rats. Psychopharmacologia (Berl.) 22, 250–260 (1971)Google Scholar
  13. Stolk, J. M., Nowack, W. J., Barchas, J. D., Platman, S. R.: Brain norepinephrine: enhanced turnover after Rb treatment. Science 168, 501–503 (1970)Google Scholar
  14. Welch, A. S., Welch, B. L.: Solvent extraction method for simultaneous determination of norepinephrine, dopamine, serotonin and 5-hydroxyindoleacetic acid in a single mouse brain. Analyt. Biochem. 30, 161–179 (1969)Google Scholar

Copyright information

© Springer-Verlag 1975

Authors and Affiliations

  • A. Judd
    • 1
  • Judith Parker
    • 1
  • F. A. Jenner
    • 1
  1. 1.Medical Research Council Unit for Metabolic Studies in Psychiatry, University Department of PsychiatryMiddlewood HospitalSheffieldEngland

Personalised recommendations